APA

Murray L. S., Lu Y., Taggart A., Van Regemorter N., Vilain C., Abramowicz M., Kadler K. E. & Van Agtmael T. (20140805). Chemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke. : Human molecular genetics.

Chicago

Murray Lydia S, Lu Yinhui, Taggart Aislynn, Van Regemorter Nicole, Vilain Catheline, Abramowicz Marc, Kadler Karl E and Van Agtmael Tom. 20140805. Chemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke. : Human molecular genetics.

Harvard

Murray L. S., Lu Y., Taggart A., Van Regemorter N., Vilain C., Abramowicz M., Kadler K. E. and Van Agtmael T. (20140805). Chemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke. : Human molecular genetics.

MLA

Murray Lydia S, Lu Yinhui, Taggart Aislynn, Van Regemorter Nicole, Vilain Catheline, Abramowicz Marc, Kadler Karl E and Van Agtmael Tom. Chemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke. : Human molecular genetics. 20140805.